chr17-4932773-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000173.7(GP1BA):c.169A>G(p.Asn57Asp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N57H) has been classified as Pathogenic.
Frequency
Consequence
NM_000173.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GP1BA | NM_000173.7 | c.169A>G | p.Asn57Asp | missense_variant | 2/2 | ENST00000329125.6 | NP_000164.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GP1BA | ENST00000329125.6 | c.169A>G | p.Asn57Asp | missense_variant | 2/2 | 1 | NM_000173.7 | ENSP00000329380 | P1 | |
CHRNE | ENST00000649830.1 | c.-888+1569T>C | intron_variant | ENSP00000496907 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bernard-Soulier syndrome, type A2, autosomal dominant Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
GP1BA-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 01, 2023 | The GP1BA c.169A>G variant is predicted to result in the amino acid substitution p.Asn57Asp. This variant has been reported in the heterozygous state in an individual with Bernard-Soulier syndrome (Table S2, Megy et al. 2021. PubMed ID: 34355501). This variant has also been reported in the heterozygous state in an individual with thrombocytopenia (Marconi et al. 2022. PubMed ID: 36519321). A different substitution of the same amino acid residue defined as p.Asn57His was reported in a patient with Bernard-Soulier syndrome (BSS) (legacy nomenclature N41H, Berndt and Andrews. 2011. PubMed ID: 21357716). The p.Asn57His substitution was also reported in the heterozygous state in two families with Bernard-Soulier syndrome and functional studies suggest this variant alters a region of the GP1BA protein required for VWF binding (Vettore et al. 2008. PubMed ID: 18815197). Another variant of the same amino acid residue, defined as p.Asn57Lys, is reported as likely pathogenic in ClinVar and is reported in the heterozygous state in a patient with a platelet-related bleeding disorder (suppl3, Downes et al. 2019. PubMed ID: 31064749). These data suggest that substitution of amino acid residue p.Asn57 is not tolerated. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In Clinvar, this variant is interpreted as like pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/1676741/). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.